Chapter 488: Biology of Aging¶
Chapter 488 | Part 18: Aging
KEY CLINICAL POINTS¶
- Aging is a progressive process characterized by molecular and cellular changes that increase susceptibility to disease and mortality.
- Theories of aging include mutation accumulation, antagonistic pleiotropy, and disposable soma theory, which explain evolutionary mechanisms of aging.
- Biological hallmarks of aging include genomic instability, epigenetic alterations, telomere attrition, and mitochondrial dysfunction.
- Caloric restriction (CR) and intermittent fasting are interventions that delay aging by modulating nutrient-sensing pathways like mTOR and AMPK.
- Pharmacologic agents such as metformin, resveratrol, and rapamycin show promise in extending lifespan and improving healthspan in preclinical models.
1. DEFINITION & OVERVIEW¶
Aging is a progressive process associated with deterioration in structure and function, leading to increased susceptibility to disease and mortality. It is characterized by biological, phenotypic, and statistical components. The disposable soma theory posits that evolution prioritizes reproductive success over somatic maintenance, leading to age-related damage. The grandmother effect explains extended postreproductive survival in humans through intergenerational care.
Global Age Demographics¶
| Age Group | Population (in millions) |
|---|---|
| 65 years and older | 1,000 |
| Less than 5 years | 1,000 |
Age-Related Disease Incidence¶
| Age | Disease Incidence |
|---|---|
| 60-70 years | Ischemic heart disease |
| 70-80 years | Alzheimer’s dementia |
| 80-90 years | Cancer |
1.1 Definitions of Aging¶
Aging is defined statistically, biologically, and phenotypically. Biological definitions include molecular processes like genomic instability and mitochondrial dysfunction. Phenotypic definitions encompass chronic diseases such as dementia and osteoporosis. Statistical definitions involve exponential increases in mortality risk with age.
1.2 Theories of Aging¶
Key theories include mutation accumulation (Haldane), antagonistic pleiotropy (Williams), and disposable soma (Kirkwood). These theories explain how evolutionary pressures shape aging, with trade-offs between reproduction and somatic maintenance. Negligible senescence and programmed aging are observed in species like clams and Pacific salmon.
2. EPIDEMIOLOGY¶
The global population over 65 years has surpassed children under 5 years. Age-related diseases like dementia, cardiovascular disease, and cancer show exponential increases in incidence with age. Mortality risk follows an exponential (Gompertz) curve. Risk factors include advanced age, genetic predisposition, and lifestyle factors such as poor diet and sedentary behavior.
2.1 Demographics¶
In 2020, people over 65 years exceeded children under 5 globally. By 2030, the U.S. population aged ≥ 65 is projected to rise from 13% to 19.3%. Age-related diseases are rare below 50 years and become prevalent with advancing age.
2.2 Risk Factors¶
Extrinsic mortality (e.g., injury, infection) drives early-life selection pressures. Genetic factors, such as mutations in WRN and LMNA genes, contribute to accelerated aging syndromes. Lifestyle factors like poor nutrition and lack of physical activity exacerbate age-related pathologies.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Aging involves stochastic, nonprogrammed changes in nuclear and mitochondrial DNA repair, leading to genomic instability. Epigenetic alterations, telomere attrition, and mitochondrial dysfunction are central to aging. The disposable soma theory posits that evolutionary pressures prioritize reproductive success over somatic maintenance, leading to age-related damage.
Telomere Length and Lifespan¶
| Species | Telomere Length (base pairs) | Lifespan (years) |
|---|---|---|
| Humans | 5,000–15,000 | 70–100 |
| Mice | 15,000–20,000 | 2–3 |
| Worms | 10,000–20,000 | 2 |
3.1 Genomic Instability¶
DNA damage from oxidative stress, irradiation, and transposons accumulates with age. Mitochondrial DNA is particularly vulnerable due to proximity to free radicals and lack of repair mechanisms. Telomere shortening in blood cells correlates with aging, while telomerase activity influences lifespan in mice.
3.2 Epigenetic Alterations¶
DNA methylation patterns change with age, forming "epigenetic clocks" like the Horvath clock. Histone modifications and noncoding RNAs alter gene expression, affecting inflammation, mitochondrial function, and autophagy pathways.
4. CLINICAL FEATURES¶
Aging is associated with chronic diseases like dementia, sarcopenia, frailty, and osteoporosis. These conditions are rare below 50 years and become prevalent with age. The "grandmother effect" explains extended postreproductive survival through intergenerational care. Age-related pathologies include oxidative damage to fat, proteins, and DNA, contributing to chronic inflammation (inflammaging).
4.1 Chronic Diseases¶
Age-related diseases include Alzheimer’s dementia, cardiovascular disease, cancer, and osteoporosis. These conditions are linked to mitochondrial dysfunction, oxidative stress, and impaired proteostasis. Frailty is a multisystem syndrome characterized by multiple deficits and impaired function.
4.2 Inflammaging¶
Low-grade chronic inflammation (inflammaging) is driven by senescent cells, SASP, and chronic infections. Elevated IL-6, TNF- α , and C-reactive protein contribute to systemic inflammation, exacerbating age-related pathologies like cardiovascular disease and neurodegeneration.
5. DIFFERENTIAL DIAGNOSIS¶
Age-related diseases must be differentiated from other conditions with similar presentations. For example, dementia may mimic Alzheimer’s or vascular dementia, while sarcopenia can resemble muscle atrophy from other causes. Chronic inflammation and frailty require distinction from acute infections or metabolic disorders.
5.1 Dementia¶
Dementia must be differentiated from delirium, depression, and other cognitive disorders. Alzheimer’s dementia is distinguished by amyloid plaques and neurofibrillary tangles, while vascular dementia is linked to cerebrovascular disease.
5.2 Frailty¶
Frailty is differentiated from cachexia, malnutrition, and chronic illness. Biomarkers like grip strength, gait speed, and physical performance are used to distinguish frailty from other geriatric syndromes.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnosis of aging-related conditions involves clinical evaluation, biomarkers, and imaging. Epigenetic clocks (e.g., Horvath clock) and telomere length measurements assess biological age. Imaging techniques like MRI and CT detect age-related pathologies such as osteoporosis and vascular changes. Biomarkers include C-reactive protein, IL-6, and telomere length.
Epigenetic Clocks¶
| Clock Type | Description | Applications |
|---|---|---|
| Horvath Clock | DNA methylation-based age estimation | Biological age assessment |
| PhenoAge | Integrates DNA methylation and physiological markers | Predicts mortality risk |
6.1 Biomarkers¶
Key biomarkers include telomere length, epigenetic clocks, and inflammatory markers (IL-6, TNF- α ). Circulating ketone bodies and metabolic profiles reflect caloric restriction effects. DNA methylation patterns are used to estimate biological age.
6.2 Imaging¶
Imaging techniques like MRI and CT detect age-related changes in bone density, vascular structure, and brain atrophy. Positron emission tomography (PET) assesses metabolic activity in neurodegenerative diseases.
7. MANAGEMENT & TREATMENT¶
Interventions to delay aging include caloric restriction (CR), intermittent fasting, and pharmacologic agents like metformin, resveratrol, and rapamycin. Exercise and lifestyle modifications are critical for maintaining healthspan. Senolytics (e.g., dasatinib, quercetin) target senescent cells to reduce inflammation and age-related pathologies.
CR-Mimetics and Their Mechanisms¶
| Drug | Target Pathway | Effect |
|---|---|---|
| Metformin | AMPK, mTOR | Improves insulin sensitivity, reduces inflammation |
| Resveratrol | SIRT1 | Enhances mitochondrial function, delays aging |
| Rapamycin | mTOR | Extends lifespan, reduces age-related pathologies |
7.1 Caloric Restriction¶
CR reduces nutrient-mediated growth factor release (GH, IGF-1) and extends lifespan in rodents and primates. It improves metabolic flexibility, reduces inflammation, and enhances mitochondrial function. Periodic fasting regimens (e.g., 5:2 diet) mimic CR effects with minimal weight loss.
7.2 Pharmacologic Interventions¶
Drugs like metformin (AMPK activator), resveratrol (SIRT1 agonist), and rapamycin (mTOR inhibitor) delay aging in preclinical models. Senolytics target senescent cells to reduce inflammation and improve tissue function.
8. PROGNOSIS & COMPLICATIONS¶
Aging is a major risk factor for chronic diseases, with exponential increases in incidence and mortality. Complications include frailty, sarcopenia, and neurodegenerative diseases. Interventions like CR and senolytics may delay aging but have limited impact on lifespan in humans. Inflammaging and mitochondrial dysfunction are key contributors to age-related morbidity.
8.1 Complications¶
Age-related complications include cardiovascular disease, cancer, and neurodegeneration. Frailty is associated with increased mortality and reduced quality of life. Oxidative stress and chronic inflammation exacerbate these conditions.
8.2 Prognosis¶
Prognosis for age-related diseases is generally poor, with limited treatment options. Interventions like CR and pharmacologic agents may improve healthspan but not necessarily extend lifespan. Geroscience aims to delay aging-related pathologies through targeted therapies.
9. SPECIAL CONSIDERATIONS¶
Aging-related interventions require careful consideration in specific populations. For example, CR may reduce fertility and libido, while senolytics may have off-target effects. Exercise is beneficial for older adults but must be tailored to individual capabilities. Pharmacologic agents like metformin require monitoring for side effects in elderly patients.
9.1 Pregnancy and Pediatrics¶
Aging interventions are not typically applied to children or pregnant women. However, maternal age-related complications (e.g., gestational diabetes) require targeted management.
9.2 Elderly Patients¶
Elderly patients may benefit from CR and exercise but require careful monitoring for adverse effects. Senolytics and anti-inflammatory agents may improve quality of life but have limited evidence for lifespan extension.
10. KEY POINTS & CLINICAL PEARLS¶
Aging is a complex process involving molecular, cellular, and systemic changes. Key interventions include CR, intermittent fasting, and pharmacologic agents targeting nutrient-sensing pathways. Epigenetic clocks and biomarkers like telomere length help assess biological age. Senolytics and anti-inflammatory therapies may reduce age-related pathologies but require further clinical validation.